Catalytic Double Cyclization Process for Antitumor Agents against Breast Cancer Cell Lines.
Ontology highlight
ABSTRACT: The development of efficient synthetic strategies for the discovery of novel antitumor molecules is a major goal in current research. In this context, we report here a catalytic double cyclization process leading to bicyclic heterocycles with significant antitumor activity on different human breast cancer (BC) cell lines. The products, 6,6a-dihydrofuro[3,2-b]furan-2(5H)-ones, were obtained in one step, starting from simple substrates (4-yne-1,3-diols, CO, and O2), under the catalytic action of PdI2 in conjunction with KI. These compounds have significant antiproliferative activity in vitro on human BC cell lines, both hormone receptor positive (MCF-7) and triple negative (triple-negative breast cancer [TNBC]; MDA-MB-231 and MDAMB-468), while exhibiting practically no
SUBMITTER: Mancuso R
PROVIDER: S-EPMC6137400 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature
ACCESS DATA